nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—CHRM3—ureter—kidney cancer	0.027	0.683	CbGeAlD
Atropine—CYP1A2—Pazopanib—kidney cancer	0.00853	0.436	CbGbCtD
Atropine—CYP1A2—urine—kidney cancer	0.00666	0.169	CbGeAlD
Atropine—CYP1A2—Erlotinib—kidney cancer	0.00609	0.311	CbGbCtD
Atropine—CYP1A2—Sorafenib—kidney cancer	0.00495	0.253	CbGbCtD
Atropine—Granisetron—CYP1A1—kidney cancer	0.0045	0.479	CrCbGaD
Atropine—Cyclopentolate—BCHE—kidney cancer	0.00354	0.377	CrCbGaD
Atropine—CHRM3—renal system—kidney cancer	0.00215	0.0543	CbGeAlD
Atropine—CHRM3—kidney—kidney cancer	0.00207	0.0525	CbGeAlD
Atropine—CYP1A2—renal system—kidney cancer	0.00163	0.0412	CbGeAlD
Atropine—Scopolamine—ABCB1—kidney cancer	0.00135	0.143	CrCbGaD
Atropine—Chest pain—Gemcitabine—kidney cancer	0.00067	0.000738	CcSEcCtD
Atropine—Asthenia—Erlotinib—kidney cancer	0.000664	0.000731	CcSEcCtD
Atropine—Mental disorder—Paclitaxel—kidney cancer	0.000663	0.000731	CcSEcCtD
Atropine—Urticaria—Sorafenib—kidney cancer	0.000661	0.000728	CcSEcCtD
Atropine—Erythema—Paclitaxel—kidney cancer	0.000659	0.000726	CcSEcCtD
Atropine—Diarrhoea—Vinblastine—kidney cancer	0.000658	0.000725	CcSEcCtD
Atropine—Abdominal pain—Sorafenib—kidney cancer	0.000658	0.000725	CcSEcCtD
Atropine—Body temperature increased—Sorafenib—kidney cancer	0.000658	0.000725	CcSEcCtD
Atropine—Diarrhoea—Everolimus—kidney cancer	0.000656	0.000722	CcSEcCtD
Atropine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000655	0.000721	CcSEcCtD
Atropine—Hyperhidrosis—Vincristine—kidney cancer	0.000655	0.000721	CcSEcCtD
Atropine—Pruritus—Erlotinib—kidney cancer	0.000654	0.000721	CcSEcCtD
Atropine—Fatigue—Dactinomycin—kidney cancer	0.000654	0.00072	CcSEcCtD
Atropine—Pain—Dactinomycin—kidney cancer	0.000648	0.000714	CcSEcCtD
Atropine—Tension—Paclitaxel—kidney cancer	0.000647	0.000712	CcSEcCtD
Atropine—Dysgeusia—Paclitaxel—kidney cancer	0.000645	0.000711	CcSEcCtD
Atropine—Eczema—Doxorubicin—kidney cancer	0.000644	0.00071	CcSEcCtD
Atropine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000642	0.000708	CcSEcCtD
Atropine—Oedema—Gemcitabine—kidney cancer	0.000642	0.000708	CcSEcCtD
Atropine—Eye pain—Doxorubicin—kidney cancer	0.000641	0.000706	CcSEcCtD
Atropine—Nervousness—Paclitaxel—kidney cancer	0.00064	0.000705	CcSEcCtD
Atropine—Dizziness—Vinblastine—kidney cancer	0.000636	0.000701	CcSEcCtD
Atropine—Dizziness—Everolimus—kidney cancer	0.000634	0.000698	CcSEcCtD
Atropine—Abdominal pain—Sunitinib—kidney cancer	0.000633	0.000697	CcSEcCtD
Atropine—Body temperature increased—Sunitinib—kidney cancer	0.000633	0.000697	CcSEcCtD
Atropine—Diarrhoea—Erlotinib—kidney cancer	0.000633	0.000697	CcSEcCtD
Atropine—Hypotension—Vincristine—kidney cancer	0.000633	0.000697	CcSEcCtD
Atropine—Bradycardia—Capecitabine—kidney cancer	0.000633	0.000697	CcSEcCtD
Atropine—Feeling abnormal—Dactinomycin—kidney cancer	0.000625	0.000688	CcSEcCtD
Atropine—Vision blurred—Paclitaxel—kidney cancer	0.000621	0.000684	CcSEcCtD
Atropine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000621	0.000684	CcSEcCtD
Atropine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00062	0.000683	CcSEcCtD
Atropine—Hypersensitivity—Sorafenib—kidney cancer	0.000613	0.000675	CcSEcCtD
Atropine—Insomnia—Vincristine—kidney cancer	0.000613	0.000675	CcSEcCtD
Atropine—Vomiting—Vinblastine—kidney cancer	0.000612	0.000674	CcSEcCtD
Atropine—Dizziness—Erlotinib—kidney cancer	0.000612	0.000674	CcSEcCtD
Atropine—Vomiting—Everolimus—kidney cancer	0.000609	0.000671	CcSEcCtD
Atropine—Agitation—Paclitaxel—kidney cancer	0.000606	0.000667	CcSEcCtD
Atropine—Rash—Everolimus—kidney cancer	0.000604	0.000666	CcSEcCtD
Atropine—Dermatitis—Everolimus—kidney cancer	0.000604	0.000665	CcSEcCtD
Atropine—Headache—Vinblastine—kidney cancer	0.000603	0.000664	CcSEcCtD
Atropine—Angioedema—Paclitaxel—kidney cancer	0.000602	0.000663	CcSEcCtD
Atropine—Headache—Everolimus—kidney cancer	0.000601	0.000662	CcSEcCtD
Atropine—Hypotension—Gemcitabine—kidney cancer	0.0006	0.000661	CcSEcCtD
Atropine—Abdominal pain—Dactinomycin—kidney cancer	0.000599	0.00066	CcSEcCtD
Atropine—Body temperature increased—Dactinomycin—kidney cancer	0.000599	0.00066	CcSEcCtD
Atropine—Asthenia—Sorafenib—kidney cancer	0.000597	0.000658	CcSEcCtD
Atropine—Hypoglycaemia—Doxorubicin—kidney cancer	0.000593	0.000653	CcSEcCtD
Atropine—Vertigo—Paclitaxel—kidney cancer	0.000592	0.000652	CcSEcCtD
Atropine—Syncope—Paclitaxel—kidney cancer	0.000591	0.000651	CcSEcCtD
Atropine—Lethargy—Doxorubicin—kidney cancer	0.000591	0.000651	CcSEcCtD
Atropine—Hypersensitivity—Sunitinib—kidney cancer	0.00059	0.00065	CcSEcCtD
Atropine—Pruritus—Sorafenib—kidney cancer	0.000589	0.000648	CcSEcCtD
Atropine—Vomiting—Erlotinib—kidney cancer	0.000588	0.000648	CcSEcCtD
Atropine—Fatigue—Vincristine—kidney cancer	0.000584	0.000643	CcSEcCtD
Atropine—Rash—Erlotinib—kidney cancer	0.000583	0.000642	CcSEcCtD
Atropine—Dermatitis—Erlotinib—kidney cancer	0.000583	0.000642	CcSEcCtD
Atropine—Palpitations—Paclitaxel—kidney cancer	0.000582	0.000642	CcSEcCtD
Atropine—Hyponatraemia—Doxorubicin—kidney cancer	0.000581	0.00064	CcSEcCtD
Atropine—Insomnia—Gemcitabine—kidney cancer	0.000581	0.00064	CcSEcCtD
Atropine—Headache—Erlotinib—kidney cancer	0.000579	0.000638	CcSEcCtD
Atropine—Loss of consciousness—Paclitaxel—kidney cancer	0.000579	0.000638	CcSEcCtD
Atropine—Pain—Vincristine—kidney cancer	0.000579	0.000638	CcSEcCtD
Atropine—Constipation—Vincristine—kidney cancer	0.000579	0.000638	CcSEcCtD
Atropine—Osteoarthritis—Doxorubicin—kidney cancer	0.000579	0.000638	CcSEcCtD
Atropine—Flushing—Capecitabine—kidney cancer	0.000577	0.000635	CcSEcCtD
Atropine—Asthenia—Sunitinib—kidney cancer	0.000574	0.000633	CcSEcCtD
Atropine—Dyspnoea—Gemcitabine—kidney cancer	0.000573	0.000631	CcSEcCtD
Atropine—Nausea—Vinblastine—kidney cancer	0.000572	0.00063	CcSEcCtD
Atropine—Somnolence—Gemcitabine—kidney cancer	0.000571	0.000629	CcSEcCtD
Atropine—Convulsion—Paclitaxel—kidney cancer	0.000571	0.000629	CcSEcCtD
Atropine—Nausea—Everolimus—kidney cancer	0.000569	0.000627	CcSEcCtD
Atropine—Diarrhoea—Sorafenib—kidney cancer	0.000569	0.000627	CcSEcCtD
Atropine—Pruritus—Sunitinib—kidney cancer	0.000566	0.000624	CcSEcCtD
Atropine—Chest pain—Paclitaxel—kidney cancer	0.000561	0.000618	CcSEcCtD
Atropine—Anxiety—Paclitaxel—kidney cancer	0.000559	0.000616	CcSEcCtD
Atropine—Hypersensitivity—Dactinomycin—kidney cancer	0.000558	0.000615	CcSEcCtD
Atropine—Arrhythmia—Capecitabine—kidney cancer	0.000555	0.000611	CcSEcCtD
Atropine—Fatigue—Gemcitabine—kidney cancer	0.000554	0.00061	CcSEcCtD
Atropine—Gastrointestinal pain—Vincristine—kidney cancer	0.000554	0.00061	CcSEcCtD
Atropine—Cardiac arrest—Doxorubicin—kidney cancer	0.00055	0.000606	CcSEcCtD
Atropine—Dizziness—Sorafenib—kidney cancer	0.00055	0.000606	CcSEcCtD
Atropine—Constipation—Gemcitabine—kidney cancer	0.000549	0.000605	CcSEcCtD
Atropine—Pain—Gemcitabine—kidney cancer	0.000549	0.000605	CcSEcCtD
Atropine—Nausea—Erlotinib—kidney cancer	0.000549	0.000605	CcSEcCtD
Atropine—Dry mouth—Paclitaxel—kidney cancer	0.000549	0.000604	CcSEcCtD
Atropine—Diarrhoea—Sunitinib—kidney cancer	0.000548	0.000603	CcSEcCtD
Atropine—Ataxia—Doxorubicin—kidney cancer	0.000544	0.0006	CcSEcCtD
Atropine—Mental disorder—Capecitabine—kidney cancer	0.000544	0.0006	CcSEcCtD
Atropine—Asthenia—Dactinomycin—kidney cancer	0.000544	0.000599	CcSEcCtD
Atropine—Confusional state—Paclitaxel—kidney cancer	0.000542	0.000597	CcSEcCtD
Atropine—Erythema—Capecitabine—kidney cancer	0.000541	0.000596	CcSEcCtD
Atropine—Dehydration—Doxorubicin—kidney cancer	0.000538	0.000593	CcSEcCtD
Atropine—Oedema—Paclitaxel—kidney cancer	0.000538	0.000593	CcSEcCtD
Atropine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000538	0.000593	CcSEcCtD
Atropine—Abdominal pain—Vincristine—kidney cancer	0.000535	0.00059	CcSEcCtD
Atropine—Body temperature increased—Vincristine—kidney cancer	0.000535	0.00059	CcSEcCtD
Atropine—Dry skin—Doxorubicin—kidney cancer	0.000531	0.000585	CcSEcCtD
Atropine—Dysgeusia—Capecitabine—kidney cancer	0.00053	0.000583	CcSEcCtD
Atropine—Dizziness—Sunitinib—kidney cancer	0.000529	0.000583	CcSEcCtD
Atropine—Feeling abnormal—Gemcitabine—kidney cancer	0.000529	0.000583	CcSEcCtD
Atropine—Shock—Paclitaxel—kidney cancer	0.000529	0.000583	CcSEcCtD
Atropine—Vomiting—Sorafenib—kidney cancer	0.000529	0.000583	CcSEcCtD
Atropine—Hypokalaemia—Doxorubicin—kidney cancer	0.000527	0.00058	CcSEcCtD
Atropine—Tachycardia—Paclitaxel—kidney cancer	0.000525	0.000578	CcSEcCtD
Atropine—Rash—Sorafenib—kidney cancer	0.000525	0.000578	CcSEcCtD
Atropine—Dermatitis—Sorafenib—kidney cancer	0.000524	0.000577	CcSEcCtD
Atropine—Headache—Sorafenib—kidney cancer	0.000521	0.000574	CcSEcCtD
Atropine—Hyperhidrosis—Paclitaxel—kidney cancer	0.00052	0.000573	CcSEcCtD
Atropine—Diarrhoea—Dactinomycin—kidney cancer	0.000519	0.000571	CcSEcCtD
Atropine—Vision blurred—Capecitabine—kidney cancer	0.00051	0.000561	CcSEcCtD
Atropine—Vomiting—Sunitinib—kidney cancer	0.000509	0.000561	CcSEcCtD
Atropine—Body temperature increased—Gemcitabine—kidney cancer	0.000508	0.000559	CcSEcCtD
Atropine—Rash—Sunitinib—kidney cancer	0.000505	0.000556	CcSEcCtD
Atropine—Dermatitis—Sunitinib—kidney cancer	0.000504	0.000556	CcSEcCtD
Atropine—Abdominal distension—Doxorubicin—kidney cancer	0.000504	0.000555	CcSEcCtD
Atropine—Hypotension—Paclitaxel—kidney cancer	0.000503	0.000554	CcSEcCtD
Atropine—Headache—Sunitinib—kidney cancer	0.000502	0.000553	CcSEcCtD
Atropine—Dysphagia—Doxorubicin—kidney cancer	0.0005	0.000551	CcSEcCtD
Atropine—Hypersensitivity—Vincristine—kidney cancer	0.000499	0.00055	CcSEcCtD
Atropine—Nausea—Sorafenib—kidney cancer	0.000494	0.000544	CcSEcCtD
Atropine—Angina pectoris—Doxorubicin—kidney cancer	0.000487	0.000537	CcSEcCtD
Atropine—Insomnia—Paclitaxel—kidney cancer	0.000487	0.000536	CcSEcCtD
Atropine—Vertigo—Capecitabine—kidney cancer	0.000486	0.000535	CcSEcCtD
Atropine—Asthenia—Vincristine—kidney cancer	0.000486	0.000535	CcSEcCtD
Atropine—Syncope—Capecitabine—kidney cancer	0.000485	0.000534	CcSEcCtD
Atropine—Vomiting—Dactinomycin—kidney cancer	0.000482	0.000531	CcSEcCtD
Atropine—Dyspnoea—Paclitaxel—kidney cancer	0.00048	0.000528	CcSEcCtD
Atropine—Somnolence—Paclitaxel—kidney cancer	0.000478	0.000527	CcSEcCtD
Atropine—Palpitations—Capecitabine—kidney cancer	0.000478	0.000526	CcSEcCtD
Atropine—Rash—Dactinomycin—kidney cancer	0.000478	0.000526	CcSEcCtD
Atropine—Nausea—Sunitinib—kidney cancer	0.000476	0.000524	CcSEcCtD
Atropine—Loss of consciousness—Capecitabine—kidney cancer	0.000475	0.000524	CcSEcCtD
Atropine—Dyspepsia—Paclitaxel—kidney cancer	0.000473	0.000522	CcSEcCtD
Atropine—Dysuria—Doxorubicin—kidney cancer	0.000468	0.000515	CcSEcCtD
Atropine—Fatigue—Paclitaxel—kidney cancer	0.000464	0.000511	CcSEcCtD
Atropine—Diarrhoea—Vincristine—kidney cancer	0.000463	0.00051	CcSEcCtD
Atropine—Asthenia—Gemcitabine—kidney cancer	0.000461	0.000508	CcSEcCtD
Atropine—Chest pain—Capecitabine—kidney cancer	0.00046	0.000507	CcSEcCtD
Atropine—Constipation—Paclitaxel—kidney cancer	0.00046	0.000507	CcSEcCtD
Atropine—Pain—Paclitaxel—kidney cancer	0.00046	0.000507	CcSEcCtD
Atropine—Anxiety—Capecitabine—kidney cancer	0.000459	0.000505	CcSEcCtD
Atropine—Pruritus—Gemcitabine—kidney cancer	0.000455	0.000501	CcSEcCtD
Atropine—Hyperglycaemia—Doxorubicin—kidney cancer	0.000451	0.000497	CcSEcCtD
Atropine—Dry mouth—Capecitabine—kidney cancer	0.00045	0.000496	CcSEcCtD
Atropine—Nausea—Dactinomycin—kidney cancer	0.00045	0.000496	CcSEcCtD
Atropine—Dizziness—Vincristine—kidney cancer	0.000448	0.000493	CcSEcCtD
Atropine—Drowsiness—Doxorubicin—kidney cancer	0.000446	0.000491	CcSEcCtD
Atropine—Confusional state—Capecitabine—kidney cancer	0.000445	0.00049	CcSEcCtD
Atropine—Feeling abnormal—Paclitaxel—kidney cancer	0.000443	0.000488	CcSEcCtD
Atropine—Oedema—Capecitabine—kidney cancer	0.000441	0.000486	CcSEcCtD
Atropine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00044	0.000485	CcSEcCtD
Atropine—Diarrhoea—Gemcitabine—kidney cancer	0.00044	0.000484	CcSEcCtD
Atropine—Shock—Capecitabine—kidney cancer	0.000434	0.000478	CcSEcCtD
Atropine—Conjunctivitis—Doxorubicin—kidney cancer	0.000434	0.000478	CcSEcCtD
Atropine—Tachycardia—Capecitabine—kidney cancer	0.000431	0.000475	CcSEcCtD
Atropine—Vomiting—Vincristine—kidney cancer	0.000431	0.000474	CcSEcCtD
Atropine—Sweating—Doxorubicin—kidney cancer	0.000428	0.000471	CcSEcCtD
Atropine—Urticaria—Paclitaxel—kidney cancer	0.000427	0.000471	CcSEcCtD
Atropine—Rash—Vincristine—kidney cancer	0.000427	0.00047	CcSEcCtD
Atropine—Hyperhidrosis—Capecitabine—kidney cancer	0.000427	0.00047	CcSEcCtD
Atropine—Dermatitis—Vincristine—kidney cancer	0.000427	0.00047	CcSEcCtD
Atropine—Body temperature increased—Paclitaxel—kidney cancer	0.000425	0.000468	CcSEcCtD
Atropine—Abdominal pain—Paclitaxel—kidney cancer	0.000425	0.000468	CcSEcCtD
Atropine—Headache—Vincristine—kidney cancer	0.000424	0.000467	CcSEcCtD
Atropine—Hypotension—Capecitabine—kidney cancer	0.000412	0.000454	CcSEcCtD
Atropine—Vomiting—Gemcitabine—kidney cancer	0.000408	0.00045	CcSEcCtD
Atropine—Bradycardia—Doxorubicin—kidney cancer	0.000408	0.000449	CcSEcCtD
Atropine—Rash—Gemcitabine—kidney cancer	0.000405	0.000446	CcSEcCtD
Atropine—Dermatitis—Gemcitabine—kidney cancer	0.000405	0.000446	CcSEcCtD
Atropine—Headache—Gemcitabine—kidney cancer	0.000402	0.000443	CcSEcCtD
Atropine—Nausea—Vincristine—kidney cancer	0.000402	0.000443	CcSEcCtD
Atropine—Insomnia—Capecitabine—kidney cancer	0.000399	0.00044	CcSEcCtD
Atropine—Hypersensitivity—Paclitaxel—kidney cancer	0.000396	0.000437	CcSEcCtD
Atropine—Dyspnoea—Capecitabine—kidney cancer	0.000394	0.000433	CcSEcCtD
Atropine—Dyspepsia—Capecitabine—kidney cancer	0.000389	0.000428	CcSEcCtD
Atropine—Asthenia—Paclitaxel—kidney cancer	0.000386	0.000425	CcSEcCtD
Atropine—Nausea—Gemcitabine—kidney cancer	0.000382	0.00042	CcSEcCtD
Atropine—Fatigue—Capecitabine—kidney cancer	0.000381	0.000419	CcSEcCtD
Atropine—Pruritus—Paclitaxel—kidney cancer	0.000381	0.000419	CcSEcCtD
Atropine—Constipation—Capecitabine—kidney cancer	0.000377	0.000416	CcSEcCtD
Atropine—Pain—Capecitabine—kidney cancer	0.000377	0.000416	CcSEcCtD
Atropine—Flushing—Doxorubicin—kidney cancer	0.000372	0.000409	CcSEcCtD
Atropine—Diarrhoea—Paclitaxel—kidney cancer	0.000368	0.000405	CcSEcCtD
Atropine—Feeling abnormal—Capecitabine—kidney cancer	0.000364	0.000401	CcSEcCtD
Atropine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000361	0.000398	CcSEcCtD
Atropine—Arrhythmia—Doxorubicin—kidney cancer	0.000358	0.000394	CcSEcCtD
Atropine—Dizziness—Paclitaxel—kidney cancer	0.000356	0.000392	CcSEcCtD
Atropine—Mental disorder—Doxorubicin—kidney cancer	0.000351	0.000387	CcSEcCtD
Atropine—Urticaria—Capecitabine—kidney cancer	0.000351	0.000386	CcSEcCtD
Atropine—Body temperature increased—Capecitabine—kidney cancer	0.000349	0.000384	CcSEcCtD
Atropine—Abdominal pain—Capecitabine—kidney cancer	0.000349	0.000384	CcSEcCtD
Atropine—Erythema—Doxorubicin—kidney cancer	0.000349	0.000384	CcSEcCtD
Atropine—Tension—Doxorubicin—kidney cancer	0.000342	0.000377	CcSEcCtD
Atropine—Vomiting—Paclitaxel—kidney cancer	0.000342	0.000377	CcSEcCtD
Atropine—Dysgeusia—Doxorubicin—kidney cancer	0.000341	0.000376	CcSEcCtD
Atropine—Rash—Paclitaxel—kidney cancer	0.000339	0.000374	CcSEcCtD
Atropine—Dermatitis—Paclitaxel—kidney cancer	0.000339	0.000373	CcSEcCtD
Atropine—Nervousness—Doxorubicin—kidney cancer	0.000339	0.000373	CcSEcCtD
Atropine—Headache—Paclitaxel—kidney cancer	0.000337	0.000371	CcSEcCtD
Atropine—Vision blurred—Doxorubicin—kidney cancer	0.000329	0.000362	CcSEcCtD
Atropine—Hypersensitivity—Capecitabine—kidney cancer	0.000325	0.000358	CcSEcCtD
Atropine—Agitation—Doxorubicin—kidney cancer	0.00032	0.000353	CcSEcCtD
Atropine—Nausea—Paclitaxel—kidney cancer	0.00032	0.000352	CcSEcCtD
Atropine—Asthenia—Capecitabine—kidney cancer	0.000317	0.000349	CcSEcCtD
Atropine—Vertigo—Doxorubicin—kidney cancer	0.000313	0.000345	CcSEcCtD
Atropine—Syncope—Doxorubicin—kidney cancer	0.000313	0.000344	CcSEcCtD
Atropine—Pruritus—Capecitabine—kidney cancer	0.000312	0.000344	CcSEcCtD
Atropine—Palpitations—Doxorubicin—kidney cancer	0.000308	0.000339	CcSEcCtD
Atropine—Loss of consciousness—Doxorubicin—kidney cancer	0.000306	0.000338	CcSEcCtD
Atropine—Convulsion—Doxorubicin—kidney cancer	0.000302	0.000333	CcSEcCtD
Atropine—Diarrhoea—Capecitabine—kidney cancer	0.000302	0.000333	CcSEcCtD
Atropine—Chest pain—Doxorubicin—kidney cancer	0.000297	0.000327	CcSEcCtD
Atropine—Anxiety—Doxorubicin—kidney cancer	0.000296	0.000326	CcSEcCtD
Atropine—Dizziness—Capecitabine—kidney cancer	0.000292	0.000322	CcSEcCtD
Atropine—Dry mouth—Doxorubicin—kidney cancer	0.00029	0.00032	CcSEcCtD
Atropine—Confusional state—Doxorubicin—kidney cancer	0.000287	0.000316	CcSEcCtD
Atropine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000285	0.000313	CcSEcCtD
Atropine—Oedema—Doxorubicin—kidney cancer	0.000285	0.000313	CcSEcCtD
Atropine—Vomiting—Capecitabine—kidney cancer	0.000281	0.000309	CcSEcCtD
Atropine—Shock—Doxorubicin—kidney cancer	0.00028	0.000308	CcSEcCtD
Atropine—Rash—Capecitabine—kidney cancer	0.000278	0.000307	CcSEcCtD
Atropine—Dermatitis—Capecitabine—kidney cancer	0.000278	0.000306	CcSEcCtD
Atropine—Tachycardia—Doxorubicin—kidney cancer	0.000278	0.000306	CcSEcCtD
Atropine—Headache—Capecitabine—kidney cancer	0.000277	0.000305	CcSEcCtD
Atropine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000275	0.000303	CcSEcCtD
Atropine—Hypotension—Doxorubicin—kidney cancer	0.000266	0.000293	CcSEcCtD
Atropine—Nausea—Capecitabine—kidney cancer	0.000262	0.000289	CcSEcCtD
Atropine—Insomnia—Doxorubicin—kidney cancer	0.000257	0.000283	CcSEcCtD
Atropine—Dyspnoea—Doxorubicin—kidney cancer	0.000254	0.000279	CcSEcCtD
Atropine—Somnolence—Doxorubicin—kidney cancer	0.000253	0.000279	CcSEcCtD
Atropine—Dyspepsia—Doxorubicin—kidney cancer	0.00025	0.000276	CcSEcCtD
Atropine—Fatigue—Doxorubicin—kidney cancer	0.000245	0.00027	CcSEcCtD
Atropine—Constipation—Doxorubicin—kidney cancer	0.000243	0.000268	CcSEcCtD
Atropine—Pain—Doxorubicin—kidney cancer	0.000243	0.000268	CcSEcCtD
Atropine—Feeling abnormal—Doxorubicin—kidney cancer	0.000234	0.000258	CcSEcCtD
Atropine—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000233	0.000256	CcSEcCtD
Atropine—Urticaria—Doxorubicin—kidney cancer	0.000226	0.000249	CcSEcCtD
Atropine—Abdominal pain—Doxorubicin—kidney cancer	0.000225	0.000248	CcSEcCtD
Atropine—Body temperature increased—Doxorubicin—kidney cancer	0.000225	0.000248	CcSEcCtD
Atropine—Hypersensitivity—Doxorubicin—kidney cancer	0.00021	0.000231	CcSEcCtD
Atropine—Asthenia—Doxorubicin—kidney cancer	0.000204	0.000225	CcSEcCtD
Atropine—Pruritus—Doxorubicin—kidney cancer	0.000201	0.000222	CcSEcCtD
Atropine—Diarrhoea—Doxorubicin—kidney cancer	0.000195	0.000214	CcSEcCtD
Atropine—Dizziness—Doxorubicin—kidney cancer	0.000188	0.000207	CcSEcCtD
Atropine—Vomiting—Doxorubicin—kidney cancer	0.000181	0.000199	CcSEcCtD
Atropine—Rash—Doxorubicin—kidney cancer	0.000179	0.000198	CcSEcCtD
Atropine—Dermatitis—Doxorubicin—kidney cancer	0.000179	0.000197	CcSEcCtD
Atropine—Headache—Doxorubicin—kidney cancer	0.000178	0.000196	CcSEcCtD
Atropine—Nausea—Doxorubicin—kidney cancer	0.000169	0.000186	CcSEcCtD
Atropine—CHRM5—Signaling by GPCR—POMC—kidney cancer	1.51e-05	0.000635	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ALAD—kidney cancer	1.5e-05	0.000632	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.46e-05	0.000617	CbGpPWpGaD
Atropine—CHRM3—Metabolism—BCHE—kidney cancer	1.45e-05	0.000609	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.43e-05	0.000603	CbGpPWpGaD
Atropine—CHRM3—Metabolism—SLC5A5—kidney cancer	1.43e-05	0.000602	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IGF2—kidney cancer	1.39e-05	0.000587	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CDKN2B—kidney cancer	1.39e-05	0.000584	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CTNNA1—kidney cancer	1.38e-05	0.000583	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CTNNA1—kidney cancer	1.38e-05	0.000581	CbGpPWpGaD
Atropine—CHRM3—Metabolism—SLC2A1—kidney cancer	1.38e-05	0.000581	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EIF4EBP1—kidney cancer	1.38e-05	0.00058	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HSPB1—kidney cancer	1.38e-05	0.00058	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HSPB1—kidney cancer	1.37e-05	0.000578	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EIF4EBP1—kidney cancer	1.37e-05	0.000578	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.37e-05	0.000578	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PGK1—kidney cancer	1.37e-05	0.000578	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CTNNA1—kidney cancer	1.37e-05	0.000576	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HSPB1—kidney cancer	1.36e-05	0.000572	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EIF4EBP1—kidney cancer	1.36e-05	0.000572	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IGF1R—kidney cancer	1.35e-05	0.000567	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—LDHB—kidney cancer	1.34e-05	0.000567	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IGF2—kidney cancer	1.33e-05	0.000562	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CDKN2B—kidney cancer	1.33e-05	0.00056	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—RAF1—kidney cancer	1.3e-05	0.000547	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IGF1R—kidney cancer	1.29e-05	0.000543	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—IL2—kidney cancer	1.28e-05	0.00054	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TSC1—kidney cancer	1.28e-05	0.000539	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ANXA1—kidney cancer	1.28e-05	0.000539	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PSMD7—kidney cancer	1.28e-05	0.000539	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ANXA1—kidney cancer	1.28e-05	0.000537	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PSMD7—kidney cancer	1.28e-05	0.000537	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TSC1—kidney cancer	1.28e-05	0.000537	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PSMD7—kidney cancer	1.26e-05	0.000532	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TSC1—kidney cancer	1.26e-05	0.000532	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ANXA1—kidney cancer	1.26e-05	0.000532	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—RAF1—kidney cancer	1.24e-05	0.000524	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—FLT1—kidney cancer	1.24e-05	0.000522	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—FLT1—kidney cancer	1.23e-05	0.00052	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—IL2—kidney cancer	1.23e-05	0.000517	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—FLT1—kidney cancer	1.22e-05	0.000515	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—POMC—kidney cancer	1.17e-05	0.000492	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CA9—kidney cancer	1.17e-05	0.000491	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—POMC—kidney cancer	1.16e-05	0.000491	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—IL2—kidney cancer	1.16e-05	0.00049	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—POMC—kidney cancer	1.15e-05	0.000486	CbGpPWpGaD
Atropine—CHRM3—Metabolism—GSTP1—kidney cancer	1.15e-05	0.000485	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—JUNB—kidney cancer	1.15e-05	0.000484	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PAK1—kidney cancer	1.15e-05	0.000484	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—JUNB—kidney cancer	1.14e-05	0.000482	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PAK1—kidney cancer	1.14e-05	0.000482	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.14e-05	0.00048	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PAK1—kidney cancer	1.13e-05	0.000478	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—JUNB—kidney cancer	1.13e-05	0.000478	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—IL2—kidney cancer	1.11e-05	0.000469	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—HIF1A—kidney cancer	1.11e-05	0.000467	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TSC2—kidney cancer	1.11e-05	0.000466	CbGpPWpGaD
Atropine—CHRM3—Metabolism—ABCB1—kidney cancer	1.09e-05	0.000459	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—HIF1A—kidney cancer	1.06e-05	0.000447	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—POMC—kidney cancer	1.06e-05	0.000447	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—KDR—kidney cancer	1.06e-05	0.000447	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TSC2—kidney cancer	1.06e-05	0.000446	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—POMC—kidney cancer	1.06e-05	0.000446	CbGpPWpGaD
Atropine—CHRM3—Metabolism—GSTM1—kidney cancer	1.06e-05	0.000445	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—POMC—kidney cancer	1.05e-05	0.000441	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—KDR—kidney cancer	1.01e-05	0.000428	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CYP1A1—kidney cancer	1e-05	0.000422	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CRABP1—kidney cancer	9.91e-06	0.000418	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—APC—kidney cancer	9.76e-06	0.000412	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—KIT—kidney cancer	9.76e-06	0.000412	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IGF2—kidney cancer	9.39e-06	0.000396	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IGF2—kidney cancer	9.36e-06	0.000394	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—MAPK3—kidney cancer	9.35e-06	0.000394	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—APC—kidney cancer	9.35e-06	0.000394	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—KIT—kidney cancer	9.35e-06	0.000394	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CDKN2B—kidney cancer	9.35e-06	0.000394	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CDKN2B—kidney cancer	9.32e-06	0.000393	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—POMC—kidney cancer	9.29e-06	0.000392	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IGF2—kidney cancer	9.27e-06	0.000391	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	9.23e-06	0.000389	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ITPR2—kidney cancer	9.22e-06	0.000388	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—BRAF—kidney cancer	9.18e-06	0.000387	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IGF1R—kidney cancer	9.08e-06	0.000383	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IGF1R—kidney cancer	9.05e-06	0.000381	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IGF1R—kidney cancer	8.96e-06	0.000378	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—MAPK3—kidney cancer	8.95e-06	0.000377	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—POMC—kidney cancer	8.9e-06	0.000375	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—MAPK1—kidney cancer	8.9e-06	0.000375	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—BRAF—kidney cancer	8.79e-06	0.00037	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—RAF1—kidney cancer	8.75e-06	0.000369	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—RAF1—kidney cancer	8.72e-06	0.000367	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—IL2—kidney cancer	8.64e-06	0.000364	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—RAF1—kidney cancer	8.63e-06	0.000364	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—IL2—kidney cancer	8.61e-06	0.000363	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—IL2—kidney cancer	8.52e-06	0.000359	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—MAPK1—kidney cancer	8.52e-06	0.000359	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—PIK3CA—kidney cancer	8.5e-06	0.000358	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.5e-06	0.000358	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ACHE—kidney cancer	8.4e-06	0.000354	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GSTT1—kidney cancer	8.4e-06	0.000354	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—KRAS—kidney cancer	8.4e-06	0.000354	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—PIK3CA—kidney cancer	8.14e-06	0.000343	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—KRAS—kidney cancer	8.05e-06	0.000339	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SCARB1—kidney cancer	7.96e-06	0.000335	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTGS1—kidney cancer	7.88e-06	0.000332	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—IL2—kidney cancer	7.84e-06	0.000331	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—IL2—kidney cancer	7.82e-06	0.000329	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—IL2—kidney cancer	7.74e-06	0.000326	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PSMD7—kidney cancer	7.72e-06	0.000326	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—PIK3CA—kidney cancer	7.72e-06	0.000325	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—RAF1—kidney cancer	7.66e-06	0.000323	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—RELA—kidney cancer	7.63e-06	0.000322	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—ERBB2—kidney cancer	7.58e-06	0.00032	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MTOR—kidney cancer	7.48e-06	0.000315	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HIF1A—kidney cancer	7.47e-06	0.000315	CbGpPWpGaD
Atropine—CHRM3—Metabolism—POMC—kidney cancer	7.47e-06	0.000315	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TSC2—kidney cancer	7.45e-06	0.000314	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HIF1A—kidney cancer	7.45e-06	0.000314	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TSC2—kidney cancer	7.43e-06	0.000313	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—PIK3CA—kidney cancer	7.39e-06	0.000312	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HIF1A—kidney cancer	7.38e-06	0.000311	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TSC2—kidney cancer	7.36e-06	0.00031	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—RAF1—kidney cancer	7.34e-06	0.000309	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—BCHE—kidney cancer	7.32e-06	0.000309	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—RELA—kidney cancer	7.31e-06	0.000308	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—ERBB2—kidney cancer	7.26e-06	0.000306	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC5A5—kidney cancer	7.23e-06	0.000305	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MTOR—kidney cancer	7.16e-06	0.000302	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KDR—kidney cancer	7.15e-06	0.000301	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KDR—kidney cancer	7.12e-06	0.0003	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KDR—kidney cancer	7.05e-06	0.000297	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CDKN1B—kidney cancer	7.02e-06	0.000296	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC2A1—kidney cancer	6.99e-06	0.000294	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL2—kidney cancer	6.87e-06	0.00029	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.78e-06	0.000286	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CDKN1B—kidney cancer	6.72e-06	0.000283	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCND1—kidney cancer	6.7e-06	0.000282	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—JUN—kidney cancer	6.68e-06	0.000282	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CTNNB1—kidney cancer	6.63e-06	0.00028	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—APC—kidney cancer	6.58e-06	0.000277	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KIT—kidney cancer	6.58e-06	0.000277	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL2—kidney cancer	6.58e-06	0.000277	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—APC—kidney cancer	6.56e-06	0.000277	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KIT—kidney cancer	6.56e-06	0.000277	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KIT—kidney cancer	6.5e-06	0.000274	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—APC—kidney cancer	6.5e-06	0.000274	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PTEN—kidney cancer	6.46e-06	0.000272	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCND1—kidney cancer	6.41e-06	0.00027	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—JUN—kidney cancer	6.4e-06	0.00027	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CTNNB1—kidney cancer	6.35e-06	0.000268	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—MAPK3—kidney cancer	6.3e-06	0.000266	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—MAPK3—kidney cancer	6.28e-06	0.000265	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—POMC—kidney cancer	6.27e-06	0.000264	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—POMC—kidney cancer	6.25e-06	0.000263	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	6.22e-06	0.000262	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PTEN—kidney cancer	6.19e-06	0.000261	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—BRAF—kidney cancer	6.19e-06	0.000261	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—POMC—kidney cancer	6.19e-06	0.000261	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—BRAF—kidney cancer	6.17e-06	0.00026	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—BRAF—kidney cancer	6.11e-06	0.000257	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—MAPK1—kidney cancer	6e-06	0.000253	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—MAPK1—kidney cancer	5.98e-06	0.000252	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PTGS2—kidney cancer	5.96e-06	0.000251	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	5.92e-06	0.00025	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.91e-06	0.000249	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—VEGFA—kidney cancer	5.84e-06	0.000246	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GSTP1—kidney cancer	5.83e-06	0.000246	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—PIK3CA—kidney cancer	5.73e-06	0.000242	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—PIK3CA—kidney cancer	5.71e-06	0.000241	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—KRAS—kidney cancer	5.67e-06	0.000239	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	5.66e-06	0.000239	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—KRAS—kidney cancer	5.65e-06	0.000238	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—KRAS—kidney cancer	5.59e-06	0.000236	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—VEGFA—kidney cancer	5.59e-06	0.000236	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MAPK3—kidney cancer	5.52e-06	0.000233	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ABCB1—kidney cancer	5.51e-06	0.000232	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MYC—kidney cancer	5.37e-06	0.000226	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GSTM1—kidney cancer	5.35e-06	0.000226	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MAPK3—kidney cancer	5.29e-06	0.000223	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MAPK1—kidney cancer	5.26e-06	0.000222	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PIK3CA—kidney cancer	5.21e-06	0.000219	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PTEN—kidney cancer	5.2e-06	0.000219	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	5.19e-06	0.000219	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—RAF1—kidney cancer	5.17e-06	0.000218	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—RAF1—kidney cancer	5.15e-06	0.000217	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MYC—kidney cancer	5.14e-06	0.000217	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—RELA—kidney cancer	5.14e-06	0.000217	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	5.14e-06	0.000217	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—RELA—kidney cancer	5.13e-06	0.000216	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ERBB2—kidney cancer	5.11e-06	0.000215	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—RAF1—kidney cancer	5.1e-06	0.000215	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ERBB2—kidney cancer	5.1e-06	0.000215	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—RELA—kidney cancer	5.08e-06	0.000214	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP1A1—kidney cancer	5.08e-06	0.000214	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ERBB2—kidney cancer	5.05e-06	0.000213	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MTOR—kidney cancer	5.04e-06	0.000213	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MAPK1—kidney cancer	5.03e-06	0.000212	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MTOR—kidney cancer	5.03e-06	0.000212	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MTOR—kidney cancer	4.98e-06	0.00021	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—KRAS—kidney cancer	4.96e-06	0.000209	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—KRAS—kidney cancer	4.75e-06	0.0002	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	4.73e-06	0.0002	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	4.72e-06	0.000199	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	4.67e-06	0.000197	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL2—kidney cancer	4.63e-06	0.000195	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL2—kidney cancer	4.62e-06	0.000195	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL2—kidney cancer	4.57e-06	0.000193	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CA—kidney cancer	4.56e-06	0.000192	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCND1—kidney cancer	4.52e-06	0.00019	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—JUN—kidney cancer	4.51e-06	0.00019	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCND1—kidney cancer	4.5e-06	0.00019	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—JUN—kidney cancer	4.49e-06	0.000189	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	4.47e-06	0.000189	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCND1—kidney cancer	4.46e-06	0.000188	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	4.46e-06	0.000188	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—JUN—kidney cancer	4.45e-06	0.000188	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	4.41e-06	0.000186	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TP53—kidney cancer	4.41e-06	0.000186	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	4.37e-06	0.000184	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PTEN—kidney cancer	4.36e-06	0.000184	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PTEN—kidney cancer	4.35e-06	0.000183	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PTEN—kidney cancer	4.3e-06	0.000181	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TP53—kidney cancer	4.23e-06	0.000178	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.17e-06	0.000176	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—VEGFA—kidney cancer	3.94e-06	0.000166	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—VEGFA—kidney cancer	3.92e-06	0.000165	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—VEGFA—kidney cancer	3.89e-06	0.000164	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—POMC—kidney cancer	3.78e-06	0.000159	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAPK3—kidney cancer	3.72e-06	0.000157	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAPK3—kidney cancer	3.71e-06	0.000156	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAPK3—kidney cancer	3.68e-06	0.000155	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CA—kidney cancer	3.67e-06	0.000155	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MYC—kidney cancer	3.62e-06	0.000153	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MYC—kidney cancer	3.61e-06	0.000152	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MYC—kidney cancer	3.58e-06	0.000151	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAPK1—kidney cancer	3.54e-06	0.000149	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAPK1—kidney cancer	3.53e-06	0.000149	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAPK1—kidney cancer	3.5e-06	0.000147	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KRAS—kidney cancer	3.35e-06	0.000141	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KRAS—kidney cancer	3.34e-06	0.000141	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KRAS—kidney cancer	3.3e-06	0.000139	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	3.08e-06	0.00013	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	3.07e-06	0.000129	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	3.04e-06	0.000128	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTGS2—kidney cancer	3.02e-06	0.000127	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TP53—kidney cancer	2.97e-06	0.000125	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TP53—kidney cancer	2.97e-06	0.000125	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TP53—kidney cancer	2.94e-06	0.000124	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTEN—kidney cancer	2.63e-06	0.000111	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.86e-06	7.83e-05	CbGpPWpGaD
